Defining remission in Rheumatoid Arthritis. New ACR/EULAR criteria

被引：7

作者：

Balsa, Alejandro ^{[1
]}

机构：

[1] Univ Autonoma Madrid, Hosp Univ Paz, Serv Reumatol, Reumatol, Madrid, Spain

来源：

REUMATOLOGIA CLINICA | 2011年 / 6卷

关键词：

Rheumatoid arthritis; Remission; Remission criteria;

D O I：

10.1016/j.reuma.2010.10.006

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Remission is the ideal treatment objective in the management of rheumatoid arthritis. To define remission, stringent criteria are needed which allow clinicians to assess the presence of active disease and which should be reliable enough to support therapeutic decisions. Currently there are many different remission classifications and none has been validated against important outcome measures such as the absence of progression of joint damage and disability. Recently, a subcommittee of the ACR and EULAR has proposed new criteria for remission based on a categorical classification and a composite score like SDAI allowing their use in clinical practice. (C) 2010 Elsevier Espana, S.L. All rights reserved.

引用

页码：S12 / S15

页数：4

共 43 条

[1] The perception of rheumatoid arthritis core set measures by rheumatologists. Results of a survey [J].

Aletaha, D. ;

Machold, K. P. ;

Nell, V. P. K. ;

Smolen, J. S. .

RHEUMATOLOGY, 2006, 45 (09) :1133-1139

[2] Remission and active disease in rheumatoid arthritis - Defining criteria for disease activity states [J].

Aletaha, D ;

Ward, MM ;

Machold, KP ;

Nell, VPK ;

Stamm, T ;

Smolen, JS .

ARTHRITIS AND RHEUMATISM, 2005, 52 (09) :2625-2636

[3]

Aletaha D, 2006, CLIN EXP RHEUMAT S43, V24, pS

[4]

Balsa A, 2004, J RHEUMATOL, V31, P40

[5] Superiority of SDAI over DAS-28 in assessment of remission in rheumatoid arthritis patients using power Doppler ultrasonography as a gold standard [J].

Balsa, Alejandro ;

de Miguel, Eugenio ;

Castillo, Concepcion ;

Peiteado, Diana ;

Martin-Mola, Emilio .

RHEUMATOLOGY, 2010, 49 (04) :683-690

[6]

BOERS M, 1993, J RHEUMATOL, V20, P568

[7] The PREMIER study - A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment [J].

Breedveld, FC ;

Weisman, MH ;

Kavanaugh, AF ;

Cohen, SB ;

Pavelka, K ;

van Vollenhoven, R ;

Sharp, J ;

Perez, JL ;

Spencer-Green, GT .

ARTHRITIS AND RHEUMATISM, 2006, 54 (01) :26-37

[8] An Explanation for the Apparent Dissociation Between Clinical Remission and Continued Structural Deterioration in Rheumatoid Arthritis [J].

Brown, A. K. ;

Conaghan, P. G. ;

Karim, Z. ;

Quinn, M. A. ;

Ikeda, K. ;

Peterfy, C. G. ;

Hensor, E. ;

Wakefield, R. J. ;

O'Connor, P. J. ;

Emery, P. .

ARTHRITIS AND RHEUMATISM, 2008, 58 (10) :2958-2967

[9] Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission - Evidence from an imaging study may explain structural progression [J].

Brown, A. K. ;

Quinn, M. A. ;

Karim, Z. ;

Conaghan, P. G. ;

Peterfy, C. G. ;

Hensor, E. ;

Wakefield, R. J. ;

O'Connor, P. J. ;

Emery, P. .

ARTHRITIS AND RHEUMATISM, 2006, 54 (12) :3761-3773

[10] Combination of infliximab and methotrexate therapy for early rheumatoid arthritis - A randomized, controlled trial [J].

Clair, EWS ;

van der Heijde, DMFM ;

Smolen, JS ;

Maini, RN ;

Bathon, JM ;

Emery, P ;

Keystone, E ;

Schiff, M ;

Kalden, JR ;

Wang, B ;

DeWoody, K ;

Weiss, R ;

Baker, D .

ARTHRITIS AND RHEUMATISM, 2004, 50 (11) :3432-3443

← 1 2 3 4 5 →